| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
SVP, Clinical Development
1 company
Xu Cong Claire is a SVP, Clinical Development at NovaBridge Biosciences. Recent SEC Form 4 filings include 0 buys and 1 sell.
Estimated insider holdings value: $435K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | NBP Novabridge Biosciences | SVP, Clinical Development | Sale+OE | 3,494 | $3.94 | $13,766.36 | -1.2% | - | - |